Ikonisys SA Total Liabilities
Ikonisys SA total liabilities. Based on the latest financial reports, Ikonisys SA (ALIKO) has total liabilities worth €7.50 Million EUR (≈ $8.77 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ALIKO cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Ikonisys SA (2019–2024)
Total liabilities of Ikonisys SA from 2019 to 2024. This chart illustrates how Ikonisys SA's total liabilities have evolved over time, based on quarterly financial data.
Ikonisys SA Competitors by Total Liabilities
The table below lists competitors of Ikonisys SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zee Learn Limited
NSE:ZEELEARN
|
India | Rs13.58 Billion |
|
Schlatter Industries AG
SW:STRN
|
Switzerland | CHF43.72 Million |
|
AIxCrypto Holdings, Inc.
NASDAQ:AIXC
|
USA | $1.72 Million |
|
Nucletron Electronic Aktiengesellschaft
F:NUC
|
Germany | €2.08 Million |
|
PLYTEC Holding Berhad
KLSE:0289
|
Malaysia | RM139.42 Million |
|
Naas Technology Inc ADR
NASDAQ:NAAS
|
USA | $1.26 Billion |
|
Huachen AI Parking Management Technology Holding Co Ltd
NASDAQ:HCAI
|
USA | $6.79 Million |
|
BBC Co. Ltd.
KQ:318410
|
Korea | ₩15.50 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Ikonisys SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ALIKO total asset value.
Liquidity & Leverage Metrics
Ikonisys SA Total Liabilities Ratios Explained
Ikonisys SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ikonisys SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ikonisys SA (2019–2024)
The table below shows the annual total liabilities of Ikonisys SA from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €13.14 Million ≈ $15.37 Million |
+156.73% |
| 2023-12-31 | €5.12 Million ≈ $5.99 Million |
+26.61% |
| 2022-12-31 | €4.04 Million ≈ $4.73 Million |
+61.43% |
| 2021-12-31 | €2.50 Million ≈ $2.93 Million |
+5.01% |
| 2020-12-31 | €2.39 Million ≈ $2.79 Million |
+16.79% |
| 2019-12-31 | €2.04 Million ≈ $2.39 Million |
-- |
About Ikonisys SA
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the flu… Read more